This is an international, one day and a half workshop in which international experts will present the hot topics
in the management of aging people. One European meeting in Barcelona and a second meeting in Buenos
Aires during 2017, will be held.
|FIRST DAY: 24th November (Pau Gil Auditorium)|
|15-17h||Aging in HIV disease||Chairman: Pedro Cahn and Bonaventura Clotet|
|Increased and accelerated age-related complications in HIV-infected patients.||Giovanni Guaraldi|
|Polypharmacy and drug-drug interactions.||David Back|
|The effects of age and HIV on neuropsychological performance||Scott Letendre|
|Switching antiretroviral therapy to safer strategies based on integrase inhibitors.||Paddy Mallon|
|17.30-19.30h||Overview of our HIV aging population: Current and future requirements.||Chairman: Peter Reiss|
|Results from questionnaires.
Objective: Previously to the Workshop a questionnaire will be collected from patients aged 55 years or over of different centres to identify the needs of this population. Data will be presented and discussed among the participants in this round table.
|Round table||Han Nefkens (Community representative)
Jose Antonio Serra (Geriatrician)
|19:30-21:30h||Poster discussion and Dinner (Sala Hipòstila)|
|Abstracts: Oral presentations.
Objective: The 2 best abstracts will be presented (5 minutes for presentation + 5 minutes for questions). Each will receive a prize, first 1000€ and the second 500€. The remaining accepted abstracts will be discussed as a poster during the dinner time.
|SECOND DAY: 25th November (Pau Gil Auditorium)|
|9-10:30h||Basis of accelerated aging in HIV-infected patients||Chairman: Bonaventura Clotet|
|Accelerated immune senescence and inflammaging||Julià Blanco|
|The microrobiome in HIV, inflammation and aging||Roger Paredes|
|The gut microbiome in frail and non-frail elders||Marc Noguera|
|11-12h||HIV and frailty: what we know and future directions||Chairman: José Antonio Serra|
|Frailty, aging and HIV||Catherine Jankowski|
|12-13h||Management of HIV drug resistance in the aging subjects.||Chairman: Roger Paredes|
|Management of HIV resistance in HIV aging patients. Switching to the most suitable regimen.||Daniele Armenia|
|14-15h||New approach to HCV||Chairman: Cristina Tural|
|Strategies for the cure of chronic and acute hepatitis C infection in HIV coinfected subjects. And after the cure?||Jürgen Rockstroh|
|15-16h||Overview of our HIV aging population: New proposals. Closing remarks.||Pedro Cahn|